Companies in Our Event Community:
From Proof-of-Concept to the Clinic:
Exploit Lipid-Carrier Properties for Nucleic Acid & Gene Therapy Delivery with Optimized Safety & Efficacy

Uncover the Potential of Novel Lipid Vehicles for Extrahepatic Delivery
From Proof-of-Concept to the Clinic: Exploit Lipid-Carrier Properties for Nucleic Acid & Gene Therapy Delivery with Optimized Safety & Efficacy
2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought leaders in the field all racing to uncover the potential of lipid-delivery properties.
This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.
Providing a complete picture of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals and beyond, join market-leaders to progress your candidates to the clinic by applying translatable insights to safeguard payload safety and efficacy.
Join AstraZeneca, Beam Therapeutics, Genentech, BMS and more to expedite the next-generation of lipid-based nanoparticle delivery systems closer to patients this August!
2023 World-Class Speaker Faculty Includes:



Jeffrey Clogston
Principal Scientist, Physiochemical Characterization Section Head
Nanotechnology Characterization Laboratory, National Cancer Institute, Leidos Biomedical Research





What to Expect at the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit:
25+
Industry & Academic Expert Presenters
140+
Nucleic-Acid & Gene Delivery Attendees
3
Jam-Packed Days of Exclusive Content
3
Deep-Dive & Collaborative Workshops
Hear From Our 2022 Attendees:
“Excellent event that is poised for massive growth.”
Principal Scientist, Merck & Co


“Great opportunity to learn in a diverse environment and with brilliant minds!”
Senior Scientist, Eli Lilly
“Congratulations event organizers for successfully conducting the 1st Next Gen Lipid-Based Nanoparticles Delivery Summit, keep going with more meetings with additional speakers from well established research and organizations in the field.”
Oligonucleotide Discovery Professional, Janssen
